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Abstract: With the aim of exploring the role of the second coordination sphere in enantioselective catalysis,
achiral organometallic catalyst precursors are anchored in proteins via non-covalent interactions. A chemo-
genetic procedure allows the activity and the enantioselectivity of the artificial metalloenzymes to be opti-
mized, to yield hybrid catalysts with features reminiscent both of enzymatic and homogeneous catalysts.
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The research theme of the Ward group is
centered on the systematic exploration of
the role of the second coordination sphere
in catalysis. This approach is motivated by
the fact that the role of the second coordi-
nation sphere is critical and often unpre-
dictable in catalysis. Two examples suffice
to illustrate our point:
i) In bioinorganic chemistry, very few
model systems which reproduce the first
coordination sphere of a metallo-coen-
zyme are as active and as selective as
the true metalloenzyme where both the
first- and the second coordination sphere
have been optimized by evolution [1].
ii) In homogeneous catalysis, the role of
the solvent and the counterion (typical
second coordination sphere interactions)
often play a determinant role in the per-
formance of a catalyst [2][3].
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In the field of homogeneous catalysis,
the steric- and the electronic control of a
catalytic moiety is primarily limited to the
first coordination sphere of the metal. This
contrasts with enzymes which take advan-
tage both of the first- and the second coor-
dination sphere to produce catalysts with
exquisite activity and selectivity. In a bio-
mimetic spirit, we incorporate active cata-
lyst precursors in a protein environment to
produce versatile artificial metalloenzymes.
Inspired by the seminal work of E.T.
Kaiser [4], several groups have recently
developed methods to covalently modify
proteins by incorporating transition-metal
catalysts to yield hybrid catalytic systems
with promising properties [5–7]. The ap-
proach delineated herein relies on non-
covalent interactions between the metal
catalyst and the protein. As no chemical
coupling step is required upon addition of
the catalyst precursor to the protein, the
integrity of the organometallic species is
warranted [8]. As suggested by Whitesides
[9][10], the biotin-avidin system offers an
attractive scaffold to perform such experi-
ments. The general concept is outlined in
Fig. 1. A baseball mitt with a deep binding
pocket epitomizes the concept of a protein
providing a chiral environment for an
organometallic catalyst precursor. 
Such an approach offers several appeal-
ing features in terms of catalyst discovery
and optimization:
i) The possibility of dissociating the ac-
tivity (primarily dictated by the organo-
metallic catalyst precursor) from the se-
lectivity (governed by the host protein).
ii) The use of orthogonal diversity-gener-
ating procedures: molecular biology for
the protein optimization as well as
parallel synthesis for the organometallic
fragment.
iii) A novel approach to exploit weak inter-
actions (i.e. supramolecular) in enantio-
selective catalysis.
As host protein, we focus on avidin and
related biotin-binding proteins. In the past
decades, the biotin-avidin technology (of-
ten referred to as molecular velcro) has
proven extremely versatile in various fields
of biotechnology [11]. Indeed, it has been
shown that derivatization of the valeric acid
side chain of biotin does not significantly
affect the remarkable affinity of biotin for
avidin (Ka ca. 1014 M–1). Although most
applications to date use a long spacer be-
tween biotin and the probe (C5 or greater),
we reasoned that a short spacer (or no spac-
er at all) would ensure that the biotinylated
catalyst precursor is located within the
protein, providing a well-defined chiral
environment for the enantiodiscrimination
event. Although egg-white avidin is com-
mercially available, its price is prohibitive
for our research. We thus set up a molecu-
lar biology laboratory to produce large
quantities of biotin-binding proteins [2].
With current molecular biological tech-
niques, we are able to rapidly generate
genetic diversity for the host protein either
by site-directed or random mutagenesis.
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Chemical diversity is achieved by vary-
ing the chelating ligand as well as by intro-
duction of an amino-acid spacer between
the biotin anchor and the organometallic
moiety (Scheme 1). Such an approach,
which relies on amide bond formation, al-
lows the synthesis of small libraries of bi-
otinylated catalyst precursors which have
demonstrated activity, but produce essen-
tially racemic product in the absence of host
protein.
As a proof-of-concept, we studied the
hydrogenation of N-protected dehydro-
amino acids to produce enantioenriched 
N-protected amino acids using biotinyla-
ted Rh-diphosphine catalyst precursors
(Scheme 1). Although hydrogenases are
known in nature, this reaction is prototypi-
cal of homogeneous catalysis. Hundreds of
efficient systems exist for such enantiose-
lective hydrogenation reactions in organic
media [13]. In aqueous media however,
much fewer systems have proven versatile
[14].
Despite the power of combinatorial
chemistry combined with molecular bio-
logical breeding techniques, the diversity
space spanned by such hybrid catalysts is
too large to be sampled efficiently by ran-
dom modifications of either the organo-
metallic catalyst or the host protein. We
thus rely on statistical tools (clustering
analysis, principal component analysis, de-
sign of experiment etc.) to design in silico
experiments that sample more systemati-
cally the diversity space with a limited
number of in vitro experiments. Our itera-
tive procedure is sketched in Fig. 2. 
Using the approach delineated above,
we produced several efficient artificial met-
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Fig. 1. Anchoring of an active achiral catalyst within a host protein with a deep binding pocket to produce enantioselective catalysts
Fig. 2. Iterative procedure for the optimization of hybrid catalysts
Scheme 1. The enantioselective hydrogenation of acetamidoacrylic acid catalyzed by bio-
tinylated rhodium-diphosphine complexes in (strept) avidin as host protein
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alloenzymes for the enantioselective hydro-
genation of acylamidoacrylic (ee up to
96%) and acylamidocinnamic acid (ee up to
88%) [15][16]. In addition to varying the
host protein, the spacer and the ligand
skeleton, we showed that both the pH and
the ionic strength of the buffered solution
play a determinant role in the activity and
the selectivity of the hybrid catalysts. As
expected, the bottleneck of this screening
procedure proved to be the ee quantifica-
tion of the products, which was performed
by GC analysis on a chiral column. 
To circumvent this problem, we recent-
ly initiated a collaboration with Prof.
Mioskowski to use competitive enzyme im-
munoassays (EIA) [17–20]. This powerful
analytical method is based on the highly
specific binding properties of antibodies
which allow the direct measurement of the
concentration of a given product in com-
plex mixtures. By using an antibody that
binds indiscriminately to the two enan-
tiomers of the product (but not to the sub-
strate), it is possible to determine the yield
from the crude reaction mixture. Deter-
mination of the ee is then deduced by
measuring the concentration of one of the
enantiomer with an enantiospecific anti-
body. 
The most interesting feature of having a
rapid ee quantification for mandelic acid is
the fact that this versatile assay can be used
for three different reactions, as summarized
in Scheme 2. Indeed, mandelic acid can be
obtained either by H2 reduction or by trans-
fer hydrogenation of phenylglyoxylate. Ad-
ditionally, kinetic resolution by oxidation
of racemic mandelic acid may afford en-
antioenriched mandelic acid which can be
quantified with the same immunoassay.
To summarize, the approach delineated
herein exploits the biotin-avidin technology
to produce artificial metalloenzymes for
enantioselective catalysis. These hybrid
catalysts operate in aqueous medium, rely
on second coordination sphere interactions
for selectivity and can be optimized by mu-
tagenesis. These features are reminiscent of
enzymes. Further, we have shown that these
hybrid catalysts display a broad substrate
tolerance and can be fine-tuned by chemi-
cal means to produce both enantiomers of
the product. These features are more remi-
niscent of homogeneous catalysts. 
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